Plain-English translation of NCT07917442 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Researchers want to understand how common small fiber neuropathy—a type of nerve damage affecting the body's smallest nerves—is in people with primary Sjögren's syndrome, an autoimmune disease that attacks moisture-producing glands. The study will use a quick, non-invasive test called Sudoscan to check nerve function and look for patterns in patients' immune systems that might explain why some people develop this nerve damage.
Nerve damage happens in some people with Sjögren's syndrome, but doctors don't know exactly how often or why. This trial aims to catch nerve damage earlier using a simple, accessible test so patients can get help sooner.
You likely qualify if…
You likely don't qualify if…
You would visit the research center for testing that includes the Sudoscan, a quick, painless test that measures how well your sweat glands are working. Researchers will also collect information about your symptoms, run blood tests to look at your immune system, and ask about how the disease affects your daily life. The study involves one main visit and is designed to be straightforward and non-invasive.
AI-generated summary from trial data · Nov 4, 2026 · Not medical advice
France
Sponsor
Centre Hospitalier Universitaire, Amiens
Enrollment target
~100 participants
Started
March 2026
Primary completion
September 2027
Age range
18 Years and older
Last updated on clinicaltrials.gov in November 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Valéry SALLE, MD
Centre Hospitalier Universitaire, Amiens
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.